Close

St. Jude Medical (STJ) Announces MOMENTUM 3 Study Met Primary Endpoint

November 16, 2016 12:35 PM EST Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced results of the MOMENTUM 3 U.S. IDE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login